Diabase Liquid
NDC Package 55714-4751-1
Package Information
Diabase (cynara, echinacea, iris vers., thuja occ., urtica ur., arg. met., arsenicum alb., aur. met., bovista, bryonia, chelidonium maj., chionanthus, gaultheria, helonias, iris vers., lycopodium, nux vom., phos., rhus tox., sabal, syzygium) liquids is formulated for symptoms such as excessive thirst or hunger, frequent urination and nerve pain. This formulation utilizes a liquid delivery system. Marketed by Newton Laboratories, Inc., this product is identified by NDC 55714-4751.
Identification & Billing
Clinical Specifications
- ARSENIC TRIOXIDE 15 [hp_X]/mL
- BRYONIA ALBA ROOT 15 [hp_X]/mL
- CHAMAELIRIUM LUTEUM ROOT 15 [hp_X]/mL
- CHELIDONIUM MAJUS 15 [hp_X]/mL
- CHIONANTHUS VIRGINICUS BARK 15 [hp_X]/mL
- CYNARA SCOLYMUS LEAF 6 [hp_X]/mL
- ECHINACEA, UNSPECIFIED 6 [hp_X]/mL
- GAULTHERIA PROCUMBENS TOP 15 [hp_X]/mL
- GOLD 15 [hp_X]/mL
- IRIS VERSICOLOR ROOT 15 [hp_X]/mL
- LYCOPERDON UTRIFORME FRUITING BODY 15 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE 15 [hp_X]/mL
- PHOSPHORUS 15 [hp_X]/mL
- SAW PALMETTO 15 [hp_X]/mL
- SILVER 15 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED 15 [hp_X]/mL
- SYZYGIUM CUMINI SEED 15 [hp_X]/mL
- THUJA OCCIDENTALIS LEAFY TWIG 6 [hp_X]/mL
- TOXICODENDRON PUBESCENS LEAF 15 [hp_X]/mL
- URTICA URENS 6 [hp_X]/mL
- Allergens - [CS]
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
- Standardized Chemical Allergen - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 55714 - Newton Laboratories, Inc.
- 55714-4751 - Diabase
- 55714-4751-1 - 30 mL in 1 BOTTLE, GLASS
- 55714-4751 - Diabase
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55714-4751-1 identifies a specific commercial package of 30 ml in 1 bottle, glass of Diabase, a human over the counter drug labeled by Newton Laboratories, Inc.. This liquid is formulated for oral use and contains arsenic trioxide; bryonia alba root; chamaelirium luteum root; chelidonium majus; chionanthus virginicus bark; cynara scolymus leaf; echinacea, unspecified; gaultheria procumbens top; gold; iris versicolor root; lycoperdon utriforme fruiting body; lycopodium clavatum spore; phosphorus; saw palmetto; silver; strychnos nux-vomica seed; syzygium cumini seed; thuja occidentalis leafy twig; toxicodendron pubescens leaf; urtica urens as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Newton Laboratories, Inc. on September 02, 2019. The current certification is valid through December 31, 2026.
How is this Newton Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55714475101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.